• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过合理的模块重组设计多样化的嵌合抗原受体

Design of diversified chimeric antigen receptors through rational module recombination.

作者信息

Si Wen, Fan Ying-Ying, Qiu Shi-Zhen, Li Xin, Wu Er-Yi, Ju Jian-Qi, Huang Wen, Wang Hao-Peng, Wei Ping

机构信息

Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

Center for Quantitative Biology and Peking-Tsinghua Joint Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.

出版信息

iScience. 2023 Mar 30;26(4):106529. doi: 10.1016/j.isci.2023.106529. eCollection 2023 Apr 21.

DOI:10.1016/j.isci.2023.106529
PMID:37102149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10123334/
Abstract

Chimeric antigen receptor (CAR)-T cells have shown great promise in cancer therapy. However, the anti-tumor efficiency is limited due to the CAR-induced T cell apoptosis or exhaustion. The intracellular domain of CAR comprised of various signaling modules orchestrates CAR-T cell behaviors. The modularity of CAR signaling domain functions as the "mainboard" to assemble diversified downstream signaling components. Here, we implemented the modular recombination strategy to construct a library of CARs with synthetic co-signaling modules adopted from immunoglobin-like superfamily (IgSF) and tumor necrosis factor receptor superfamily (TNFRSF). We quantitatively characterized the signaling behaviors of these recombinants by both NFAT and NF-κB reporter, and identified a set of new CARs with diverse signaling behaviors. Specifically, the 28(NM)-BB(MC) CAR-T cells exhibited improved cytotoxicity and T cell persistence. The synthetic approach can promote our understanding of the signaling principles of CAR molecule, and provide a powerful tool box for CAR-T cell engineering.

摘要

嵌合抗原受体(CAR)-T细胞在癌症治疗中显示出巨大的前景。然而,由于CAR诱导的T细胞凋亡或耗竭,其抗肿瘤效率受到限制。CAR的细胞内结构域由各种信号模块组成,协调CAR-T细胞的行为。CAR信号结构域的模块化充当“主板”,用于组装多样化的下游信号组件。在这里,我们实施了模块化重组策略,构建了一个CAR文库,其中采用了来自免疫球蛋白样超家族(IgSF)和肿瘤坏死因子受体超家族(TNFRSF)的合成共刺激信号模块。我们通过NFAT和NF-κB报告基因定量表征了这些重组体的信号行为,并鉴定出一组具有不同信号行为的新型CAR。具体而言,28(NM)-BB(MC)CAR-T细胞表现出改善的细胞毒性和T细胞持久性。这种合成方法可以促进我们对CAR分子信号原理的理解,并为CAR-T细胞工程提供一个强大的工具箱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/10123334/01293af2dcbc/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/10123334/01293af2dcbc/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b1/10123334/01293af2dcbc/fx1.jpg

相似文献

1
Design of diversified chimeric antigen receptors through rational module recombination.通过合理的模块重组设计多样化的嵌合抗原受体
iScience. 2023 Mar 30;26(4):106529. doi: 10.1016/j.isci.2023.106529. eCollection 2023 Apr 21.
2
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.4-1BB 共刺激和优化的 CD28 共刺激增强了人单特异性和双特异性第三代 CAR T 细胞的功能。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003354.
3
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.表达VHH导向的寡克隆嵌合HER2抗原受体的T细胞:迈向肿瘤导向的寡克隆T细胞疗法。
Biochim Biophys Acta. 2014 Jan;1840(1):378-86. doi: 10.1016/j.bbagen.2013.09.029. Epub 2013 Sep 27.
4
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling.4-1BB 共刺激促进 CAR T 细胞存活通过非经典 NF-κB 信号通路。
Sci Signal. 2020 Mar 31;13(625):eaay8248. doi: 10.1126/scisignal.aay8248.
5
4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2 Generation Chimeric Antigen Receptor-Modified T Cells.4-1BB 信号增强了嵌合抗原受体修饰的 CD28 整合第二代 T 细胞的抗肿瘤活性。
Front Immunol. 2020 Nov 13;11:539654. doi: 10.3389/fimmu.2020.539654. eCollection 2020.
6
Synthetic immunology: T-cell engineering and adoptive immunotherapy.合成免疫学:T细胞工程与过继性免疫治疗
Synth Syst Biotechnol. 2018 Sep 1;3(3):179-185. doi: 10.1016/j.synbio.2018.08.001. eCollection 2018 Sep.
7
Co-Stimulatory Receptor Signaling in CAR-T Cells.嵌合抗原受体 T 细胞共刺激受体信号。
Biomolecules. 2022 Sep 15;12(9):1303. doi: 10.3390/biom12091303.
8
Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.表达自杀基因和靶向信号淋巴细胞激活分子 F7 的嵌合抗原受体的 CAR T 细胞的开发。
Mol Ther. 2021 Feb 3;29(2):702-717. doi: 10.1016/j.ymthe.2020.10.008. Epub 2020 Oct 14.
9
4-1BB enhancement of CAR T function requires NF-κB and TRAFs.4-1BB 增强 CAR T 功能需要 NF-κB 和 TRAFs。
JCI Insight. 2018 Sep 20;3(18). doi: 10.1172/jci.insight.121322.
10
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.在嵌合抗原受体T细胞(CAR-T细胞)中实施肿瘤坏死因子受体超家族(TNFRSF)共刺激结构域以实现最佳功能活性
Cancers (Basel). 2022 Jan 8;14(2):299. doi: 10.3390/cancers14020299.

引用本文的文献

1
Dissecting the role of CAR signaling architectures on T cell activation and persistence using pooled screens and single-cell sequencing.利用混合筛选和单细胞测序剖析CAR信号结构在T细胞激活和持久性中的作用。
Sci Adv. 2025 Feb 14;11(7):eadp4008. doi: 10.1126/sciadv.adp4008.
2
High-throughput screening for optimizing adoptive T cell therapies.用于优化过继性T细胞疗法的高通量筛选
Exp Hematol Oncol. 2024 Nov 13;13(1):113. doi: 10.1186/s40164-024-00580-w.
3
CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis.

本文引用的文献

1
Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning.利用组合信号基序文库和机器学习解码 CAR T 细胞表型。
Science. 2022 Dec 16;378(6625):1194-1200. doi: 10.1126/science.abq0225. Epub 2022 Dec 8.
2
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies.CAR T 细胞的联合筛选确定了用于下一代免疫疗法的多样化免疫信号结构域。
Sci Transl Med. 2022 Nov 9;14(670):eabm1463. doi: 10.1126/scitranslmed.abm1463.
3
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.
经工程改造以分泌IFNκ的嵌合抗原受体T细胞通过IFNAR/STAT1/ACSL4轴诱导肿瘤铁死亡。
Cancer Immunol Res. 2024 Dec 3;12(12):1691-1702. doi: 10.1158/2326-6066.CIR-24-0130.
4
Novel CAR-T Cells Specifically Targeting SIA-CIgG Demonstrate Effective Antitumor Efficacy in Bladder Cancer.新型 CAR-T 细胞特异性靶向 SIA-CIgG,在膀胱癌中显示出有效的抗肿瘤疗效。
Adv Sci (Weinh). 2024 Oct;11(40):e2400156. doi: 10.1002/advs.202400156. Epub 2024 Aug 23.
5
Identification of signature genes and immune infiltration analysis in thyroid cancer based on PANoptosis related genes.基于 PANoptosis 相关基因鉴定甲状腺癌的特征基因和免疫浸润分析。
Front Endocrinol (Lausanne). 2024 Jul 22;15:1397794. doi: 10.3389/fendo.2024.1397794. eCollection 2024.
6
Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness.共刺激CD28/CD40信号分子可增强嵌合抗原受体T细胞(CAR-T)的疗效和干性。
Mol Ther Oncol. 2024 Jun 18;32(3):200837. doi: 10.1016/j.omton.2024.200837. eCollection 2024 Sep 19.
7
Programmable synthetic receptors: the next-generation of cell and gene therapies.可编程合成受体:下一代细胞和基因治疗。
Signal Transduct Target Ther. 2024 Jan 3;9(1):7. doi: 10.1038/s41392-023-01680-5.
8
Bringing cell therapy to tumors: considerations for optimal CAR binder design.将细胞疗法应用于肿瘤:优化嵌合抗原受体(CAR)结合物设计的考量因素
Antib Ther. 2023 Sep 12;6(4):225-239. doi: 10.1093/abt/tbad019. eCollection 2023 Oct.
speedingCARs:通过信号域改组和单细胞测序加速 CAR T 细胞的工程改造。
Nat Commun. 2022 Nov 2;13(1):6555. doi: 10.1038/s41467-022-34141-8.
4
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.通过带有编码的细胞内结构域文库筛选具有增强信号的 CD19 特异性嵌合抗原受体。
Nat Biomed Eng. 2022 Jul;6(7):855-866. doi: 10.1038/s41551-022-00896-0. Epub 2022 Jun 16.
5
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.CD3ε 的多重信号作用及其在 CAR-T 细胞治疗中的应用。
Cell. 2020 Aug 20;182(4):855-871.e23. doi: 10.1016/j.cell.2020.07.018. Epub 2020 Jul 29.
6
Chimeric Antigen Receptor T Cell Bearing Herpes Virus Entry Mediator Co-stimulatory Signal Domain Exhibits High Functional Potency.携带疱疹病毒进入介质共刺激信号域的嵌合抗原受体T细胞具有高效能。
Mol Ther Oncolytics. 2019 Mar 23;14:27-37. doi: 10.1016/j.omto.2019.03.002. eCollection 2019 Sep 27.
7
An immunoproteomic approach to characterize the CAR interactome and signalosome.一种免疫蛋白质组学方法,用于表征 CAR 相互作用组和信号体。
Sci Signal. 2019 Feb 12;12(568):eaap9777. doi: 10.1126/scisignal.aap9777.
8
CAR T cell immunotherapy for human cancer.嵌合抗原受体 T 细胞免疫疗法治疗人类癌症。
Science. 2018 Mar 23;359(6382):1361-1365. doi: 10.1126/science.aar6711.
9
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.通过 ICOS 和 4-1BB 共刺激增强 CAR T 细胞的持久性。
JCI Insight. 2018 Jan 11;3(1). doi: 10.1172/jci.insight.96976.
10
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.嵌合抗原受体中 4-1BB 共刺激会阻碍 T 细胞存活,且具有载体依赖性。
Cell Rep. 2017 Oct 3;21(1):17-26. doi: 10.1016/j.celrep.2017.09.015.